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Abstract
Background: The objective of this study was to examine early and long-term results of surgical aortic valvotomy in
neonates and infants aged less than four months and to identify predictors of outcome.
Methods: Between August 1994 and April 2012, 83 consecutive patients younger than 4 months of age underwent
open heart valvotomy for critical aortic stenosis in our institution. Median age was 17 days (range 0-111 days). We
examined clinical records to establish determinants of outcome and illustrate long-term results.
Results: Fifty-six patients (67 %) were neonates. Associated cardiac malformations were found in 24 patients (29 %),
including multilevel left heart obstruction in 5. The median follow-up was 4.2 years. The time-related survival rate
was 87 and 85 % at 5 and 15 years, respectively. The time-related survival without reintervention was respectively
51, 35 and 18 % at 5, 10 and 15 years. The time-related survival without aortic valve replacement was respectively
67, 54 and 39 % at 5, 10 and 15 years. Ventricular dysfunction (p = 0.04), delayed sternal closure (p = 0.007), endocardial
fibroelastosis (p = 0.02) and low z-score of the aortic annulus (p = 0.04) were found predictors of global mortality.
Ventricular dysfunction (p = 0.01) and endocardial fibroelastosis (p = 0.04) were found predictors of reintervention.
Conclusions: The experience, in our center, on the management of critical aortic stenosis, shows a low early and late
mortality, but the aortic valvotomy is a palliative procedure and we see unfortunately a high rate of reintervention
among which the aortic valve replacement. These results suggest to reconsider the use of aortic balloon valvotomy,
and particularly for the neonates with a low cardiac output in order to avoid the myocardial stress and the neurological
injury due to the cardiopulmonary bypass.
Background
Management of critical aortic stenosis in infants is still a
controversial issue [1, 2]. When the patient is considered
suitable for a biventricular repair, several options are
available: conservative surgery including open heart val-
votomy or, in some centers, closed transventricular aortic
valvotomy [3]; or transcatheter balloon dilation.
During surgical open heart valvotomy, the surgeon has
direct access to the morphology of the aortic valve and
can adapt surgical strategy to individual valvular anatomy.
In addition to dividing the zones of commissural fusion,
thick and dysplastic leaflets can be thinned, improving
valvular mobility. After surgery there is generally a low risk
of aortic regurgitation with moderate residual gradient [4].
In contrast, transcatheter balloon dilation does not
permit direct vision of the valve and tears aortic leaflets
in a random way, usually at the weakest part of the valve
and not necessarily at the level of the fused commissures.
Despite its “blind” nature, transcatheter balloon dilation is
now favored by most teams in the neonate and young in-
fant as a first-choice procedure, because of its greater facil-
ity to carry out. After percutaneous balloon valvuloplasty,
there is a higher risk of significant aortic regurgitation
but generally a lower risk of residual stenosis. Progress
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in catheter procedures using new generation balloons of
different sizes more adapted to the individual anatomic
situation of the infant makes the difference between
surgical commissurotomy and balloon valvuloplasty not
evident [5–8].
Valvotomy of any kind is a palliative procedure, and
reinterventions remain frequent [9].
In our institution, the approach to the neonate and
young infant with critical aortic stenosis eligible for
biventricular repair (size of aortic annulus not less than
five millimeters) was almost exclusively open surgical
valvotomy since 1994. Some percutaneous balloon valvulo-
plasties were performed from 1986 to 1993 and abandoned
because of occurrence of acute aortic insufficiency.
The purpose of this study was to evaluate the results
of this deliberate surgical approach, by analyzing the
mid-term outcome after surgical valvotomy in young in-
fants less than four months of age. In the current area of
the percutaneous dilation of the aortic valve, we would
like to know if we made the best choice of management
of critical aortic stenosis.
Methods
Between August 1994 and April 2012, 83 consecutive
patients younger than 4 months of age (19 girls, 64 boys)
underwent open heart valvotomy for critical aortic stenosis
in our institution. Median age was 17 days (range 0–111
days). Fifty-six patients (67 %) were neonates. Median
weight at operation was 3.5 kg (range 1.8–6.9 kg).
Definition of study group
Critical aortic stenosis was an isolated lesion in 59 pa-
tients (71 %). Associated cardiac malformations were
found in 24 patients (29 %), including multilevel left
heart obstruction in 5, aortic coarctation in 8, atrial sep-
tal defect in 5, interruption of the aortic arch in 1 (IAA),
ventricular septal defect in 2, mitral stenosis in 2, a mild
form of hypoplastic left heart syndrome (HLHS) in 1,
and supra valvular aortic stenosis with associated stenosis
of the right pulmonary artery in 1.
The surgical threshold of intervention is a mean gradi-
ent ≥ 50 mmHg or less, if the patient presents a severe
left ventricular dysfunction and/or an associated cardiac
malformation requiring a concomitant surgery.
The neonate and young infant with critical aortic sten-
osis were eligible for biventricular repair if the size of the
aortic annulus didn't measure less than five millimeters.
Clinical features
Nine patients were directly admitted in the intensive care
unit because of cardiorespiratory failure. Eight needed
ventilation support and nine needed inotropic support.
Ductal dependency was present in 14 patients who re-
quired prostaglandin E1 treatment.
The malformation had been diagnosed prenatally in 14
patients (17 %).
The pressure gradient across the aortic valve was mea-
sured by transthoracic echocardiography coupled with
continuous wave Doppler technique. Preoperative peak
and mean aortic valve gradient were respectively 86 mmHg
(range 20 to 190 mmHg) and 53 mmHg (range 14 to
106 mmHg). Aortic regurgitation grade ¼, assessed by
color-flow Doppler, was present in two patients (2,4 %).
Four patients had associated subaortic stenosis (4.8 %).
Three of four patients with subaortic stenosis were in-
cluded in the associated cardiac malformations described
in definition of study group section (one aortic coarctation
and two multilevel left heart obstructions) except one who
has an isolated aortic stenosis.
The median z-score of the aortic annulus was −1.9
(range −7.5 to 1.6), the median z-score of the ascending
aorta was 2.1 (range −3.8 to 4.7), the median z-score of
left ventricle end-diastolic diameter (LVEDD) was 0.5
(range −3.9 to 7.2) [10].
Caution should be used with these measures because,
on one hand, it's an historic series with a downstream
calculation of z-score, and, on the other hand, according
to the method of calculation of the z-score, the value of
the latter can change a lot.
Thirty-seven patients had left ventricular dysfunction
(45 %), defined as a shortening fraction (SF) < 30 %. The
median SF was 35 % (range 8 to 61 %). Endocardial
fibroelastosis (EFE) was present in 31 % of patients (de-
termined by echocardiography and confirmed by the
surgeon; The extend of EFE was not detailed).
Morphology of the aortic valve assessed at surgery
The aortic valve was bicuspid in 70 patients (84 %),
monocuspid in seven patients (9 %) and tricuspid in six
patients (7 %).
Surgical technique
After median sternotomy, right atrial cannulation, and
aortic cannulation, all patients were placed on normother-
mic cardiopulmonary bypass (CPB). Myocardial protec-
tion was obtained with hyper potassic antegrade blood
repeated at ten minutes intervals; Through a transverse
aortotomy, a careful commissurotomy of the aortic valve
was performed in order to avoid appearance of aortic re-
gurgitation (AR). Obstructive myxomatous and fibrous
nodules were removed from the leaflets. Median CPB time
was 42 min (range 13–260 min), median aortic cross-
clamping time was 20 min (range 6–69 min).
Concomitant surgery (18 %) included aortic coarctation
repair in 11 patients, IAA repair in one patient, closure of
ventricular septal defect in 1, closure of atrial septal defect
in 3, resection of supra-mitral membrane in 1, mitral com-
missurotomy in 1 and pulmonary artery banding in 1.
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The surgeon had to enlarge the sinotubular junction
with a patch in 17 patients (20.5 %) without supra-aortic
stenosis described pre-operatively. The decision was
taken by the surgeons in view of the observations during
open heart valvotomy.
Delayed sternal closure was required in 16 patients
(19 %).
Follow-up
Hospital survivors were examined in outpatient clinics
at regular intervals by their pediatric cardiologist. Two-
dimensional echocardiography and Doppler studies were
routinely performed before discharge from the hospital
and during each outpatient visit. The transvalvular aortic
peak pressure gradient was calculated using the simpli-
fied Bernoulli equation. Color-flow Doppler imaging was
used to analyze the degree of AR, using jet width and
end-diastolic velocity of the retrograde flow in the de-
scending aorta. The median follow-up was 4.2 years
(range 1 day to 17.7 years). Five patients were lost of
follow-up. Early death was defined as death in the hos-
pital or within 30 days after the operation.
Statistical analysis
The data were imported into Stat Statview 5.0 SAS
Institut Inc software. Risk factors for mortality and
reintervention were studied by univariate analysis (with
contingency coefficient (CC)), using the two-tailed paired
Student’s t test and U of Mann–Whitney for the continu-
ous variables and the χ2 test for nominal variables, and by
multivariate analysis using a logistic regression model
(with odds ratio (OR)). The actuarial method was used to
determine event-free survival curves. The level of statis-
tical significance was set at a p value of less than 0.05.
Results
Early mortality and functional status
There were five (6 %) early deaths. Two patients with
low cardiac output died on the first postoperative day. A
third patient could have been converted to Norwood
procedure but died on the first postoperative day
because the parents refused the intervention. The last
two patients died at 44 and 56 postoperative days due
to respectively a severe tricuspid regurgitation with a
restrictive mitral profile, and a low cardiac output.
These five patients were critically ill preoperatively
with severe ventricular dysfunction (two of them needed
mechanical ventilation and inotropic support) among
whom three needed a long cardiopulmonary bypass
(147,161 et 190 min). Four of them required delayed
sternal closure.
In fact, three of them were not eligible for a biventri-
cular repair with a diameter of the aortic annulus which
was less than five millimeters.
The 2D-echocardiography coupled with Doppler study
showed a postoperative mean and maximal peak aortic
valve gradient of respectively 24 mmHg (range 10 to
56 mmHg) and 37 mmHg (range 12 to 88 mmHg), sig-
nificantly lower than before surgery (p‹0.0001). There
were 58 % of AR grade 1-2/4 and one severe AR 3/4.
Seven patients had a SF < 30 % (median 37,5 %, range 21
to 56 %), which was significantly lower than before
surgery (7/77 (9 %) vs 45 %, p < 0.05).
Late mortality and reinterventions
There were six late deaths, with a global mortality of
13 % (64 % were neonates). Four of these late deaths oc-
curred early after a second intervention: during Ross
intervention in 1, on the first postoperative day after a
Ross-Konno procedure because of low cardiac output in
the second, five days after a Ross procedure associated
with mitral valvuloplasty in the third one, and the fourth
one after mitral valvotomy due to pulmonary hyperten-
sion. Two other patients died because of pulmonary
hypertension : one four years after having two aortic val-
votomies and a Ross procedure, and the last one less
than a year after aortic valvotomy.
The time-related survival rate was 87 and 85 % at 5
and 15 years, respectively (Fig. 1).
Thirty eight patients had a second intervention (46 %)
within a median period of 6.3 months (range 15 days to


















Years after initial Surgical Valvotomy 
83 38 15 6 Patients at risk 
Fig. 1 Survival curve after surgical aortic valvotomy
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– Restenosis in 27 patients (13 surgical valvotomies,
6 Ross procedures, 3 Ross-Konno, 5 balloon
valvotomies). Concomitant surgery included 7
patches of enlargement of the sinotubular
junction, 4 mitral valvotomies and 1 atrial septal
defect closure.
– Severe aortic regurgitation (AR grade ≥ 3) in
3 (2 Ross procedures and 1 Ross-Konno).
– Association of aortic stenosis and aortic regurgitation
in 7 (three AR grade 2, two AR grade 3 and two AR
grade 4) with 6 Ross procedures and 1 surgical
valvotomy. Concomitant interventions included 1
patch of enlargement of the sinotubular junction, 2
mitral and 1 tricuspid valvotomy and 1 resection of
vegetation.
– Isolated mitral stenosis in 1.
Eleven patients had a third intervention (15.5 %): 3
mitral surgical valvotomy, 1 balloon aortic valvotomy,
1 surgical aortic valvotomy with ventricular septal de-
fect closure and resection of subvalvular aortic sten-
osis, 1 right ventricle to pulmonary artery Hancock
conduit, 1 Ross-Konno procedure, 2 Ross procedures,
1 mechanical aortic valve replacement with enlarge-
ment of left pulmonary artery and 1 mechanical mitral
valve replacement. There was no death among these
patients.
Three patients had a fourth intervention (3.5 %): one
left and right coronary artery bypass, one Ross procedure
and one right ventricular to pulmonary artery conduit.
There was no death.
The time-related survival without reintervention
(surgery or balloon valvotomy) was respectively 51, 35
and 18 % at 5, 10 and 15 years (Fig. 2).
The time-related survival without surgical reinter-
vention was respectively 58, 39 and 21 % at 5, 10 and
15 years (Fig. 3).
The time-related survival without aortic valve re-
placement (AVR) was respectively 67, 54 and 39 % at 5,
10 and 15 years (Ross or mechanical aortic valve re-
placement) (Fig. 4).
There is no significant difference in survival, survival
without re-intervention and survival without AVR/Ross
between before and after 2008.
Risk factors for global mortality and reintervention
The risk factors studied were: aortic annulus diameter
left ventricular dysfunction, SF, inotropic drugs, mechan-
ical ventilation, neonatal period, weight, LVEDD, endocar-
dial fibroelastosis, delayed sternal closure because of the
higher risk of mediastinitis,, associated cardiac malforma-
tions and prenatal diagnosis.
The bicuspid valve was not studied as a risk factor be-
cause of its too high prevalence (84 % of infants had a bi-
cuspid valve). Ventricular dysfunction (p = 0.04, CC = 0,2),
delayed sternal closure (p = 0.007; OR = 21), endocardial
fibroelastosis (p = 0.02, CC = 0,3), low z-score of the
aortic annulus (p = 0.04, OR = 0,7) and prenatal diagno-
sis (p = 0,01; OR = 20) were found predictors of global
mortality.
The value of z-score of the aortic annulus for which
the risk of mortality becomes prohibitive is −3 (speci-
ficity: 0,88 and sensitivity: 0,55) with the aera under
the curve =0,66 (Fig. 5).
As regards prenatal diagnosis, the result must be inter-
preted with caution. The percentage of this latter was
low (only 17 %) because it is an historic series and only
the most severe forms were detected, what explains that
the prenatal diagnosis was found predictor of global
mortality.
Ventricular dysfunction (p = 0.01; OR = 4) and endocar-
dial fibroelastosis (p = 0.04; OR = 0,3) were found predictors
of re-intervention.
Long-term functional status
At the latest echocardiographic examination for the 50
patients still having their native aortic valve (69 % of
survivors), aortic regurgitation was null in 10, grade 1
in 18, grade 2 in 18, grade 3 in 4. The mean and maximal


































Years after initial Surgical Valvotomy 
83 18 6 2 Patients at risk
Fig. 2 Time-related survival without re-intervention after surgical aortic valvotomy
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Comment
The most appropriate management of critical aortic sten-
osis in neonates and young infants remains controversial.
Since the advent of transcatheter balloon dilatation in
1983 [11], many teams now use exclusively this technique
in this group of patients, to avoid the myocardial stress
induced by open heart surgery in these often critically ill
babies. Only a few studies are focusing only on this age
group, but most insist on the high mortality rate in
infants, whatever the technique used. Only few recent
comparative studies have concentrated on the comparison
of these two techniques in neonates [8, 12–14].
In our center, we prefer surgical treatment because of
the expertise acquired in that area, and of the higher risk
of severe aortic regurgitation with balloon valvotomy.
Surgical valvotomy is safe with low mortality and pre-
serves the native aortic valve as long as possible.
Recent studies about infants less than three months of
age show a variable rate of early (range from 0 to 19 %)
and late mortality with an actuarial survival between 73
and 91 % at 10 years, a freedom from reintervention be-
tween 41 and 78 % at 10 years, and freedom from aortic
valve replacement (mentioned in only 2 of these studies)
between 79 and 83 % at 10 years [4, 8, 15–18].
Siddiqi and al. shows that, after a period where the
treatment of choice for valvular aortic stenosis in neonates
and infants was balloon dilatation in most centers, the ten-
dency is now shifting in favor of surgical valvotomy, be-
cause of the much higher rate of reintervention in patients
undergoing balloon valvuloplasty than in surgically treated
patients [14].
Our results compare favorably to others for early mor-
tality (6 %) but our rate of reinterventions is higher
(freedom from reintervention 35 % at 10 years) with a
median delay of 6.3 months, as well as our aortic valve
replacement rate (freedom from AVR 54 % at 10 years
with a median delay of 1,2 years).
This difference of results can be partially explained by
a relatively high rate of severe associated cardiac malfor-
mations, notably five multilevel left heart obstruction,
one mitral stenosis and one HLHS, more severe hypo-
plasia of the aortic annulus (median z-score = −1.9) and
a majority of bicuspid or monocuspid valves with only
7 % of tricuspid valves.
They seemed to have improved since 2008 with a per-
centage of re-intervention s and aortic valve replace-
ments decreased by 50 % reaching respectively 28 et
21 %. However, we have finally not found a significant
difference in survival, survival without re-intervention
and survival without AVR/Ross.
We found that ventricular dysfunction and hypoplastic









































Years after initial Surgical Valvotomy 
83 21 8 3 Patients at risk































Years after initial Surgical Valvotomy 
83 27 11 5 Patients at risk
Fig. 4 Time-related survival without AVR after surgical aortic valvotomy
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with endocardial fibroelastosis and delayed sternal
closure. These results are consistent with those of
other studies [8, 14, 16, 18].
The value of z-score of the aortic annulus for which
the risk of mortality becomes prohibitive is −3. This
amounts to an aortic annulus of 5 mm, which is corre-
sponding with our attitude of surgical management on
two ventricles.
This can be illustrated by six patients of our study who
had a biventricular repair while the diameter of the aortic
annulus was lower than 5 mm; half of them died early.
We prefer to consider the ultrasound measure of the
aortic annulus at 5 mm in order to decide a biventricular
repair. In fact, according to the method of calculation of
the z-score, the value of the latter can change a lot
(Detroit, Boston Children's Hospital data,…).
We showed that left ventricular dysfunction and endocar-
dial fibroelastosis were also associated with an increased
risk of re-intervention, probably because these anomalies
lead to underestimated residual aortic gradient after the
aortic valvotomy. This is consistent with the study of
Hawkins and al. [16].
A small aortic annulus has been considered by some
to be a independent risk factor for earlyreintervention
[15, 17], but this was not the case in our study.
We did not find that the neonatal period was a risk
factor of global mortality but for others, survival in this
category of age is deemed to be inferior to that of infants
over one month of life [19, 20]. Unfortunately, this risk
factor is poorly studied in the literature. Contrarily to
our study, the neonatal period was found as a risk factor
of re-intervention in the studies where the balloon
dilatation was used, because the priority is then to
provide sufficient relief of the ventricular outflow ob-
struction to allow ventricular recovery while avoiding
severe AR [7, 14, 21, 22].
The bicuspid aortic valve was not studied as a risk factor
in our study because of its too high prevalence. However,
previous reports showed that bicuspid aortic valve was as-
sociated with an increased risk of re-intervention [15, 23].
If the surgeon can reconstruct three cusps without produ-
cing significant aortic regurgitation, the need for any re-
intervention for recurrent stenosis is less than in patients
with bicuspid valves [23]. In the study of Hraska and al.,
freedom from reintervention at 15 years was 100 and 30 %
respectively in the patients with tricuspid and monocus-
pid/bicuspid valves [15].
As in other studies, the main cause for reintervention
in our patients group was aortic restenosis. Despite the
fact that late mortality was mainly related to reinterven-
tions, several procedures can be performed in the same
patient without impairing heart function. Another notable
cause of early and late mortality, still not fully understood,
is pulmonary hypertension. Endocardial fibroelastosis is
common in neonates with critical aortic stenosis. These
myocardial changes could explained an increased left ven-
tricular end diastolic pressure and a persistent pulmonary
hypertension several years after aortic valvotomy without
recurrent left ventricular outflow tract obstruction [24].
Pulmonary hypertension is a well known consequence of
restrictive cardiomyopathy [25] and isolated endocardial
fibroelastosis [26]. Perhaps, we should consider additional
surgical approaches such as left ventricular endocardial re-
section in order to limit the ventricular remodeling and
the development of diastolic left ventricular dysfunction.
Balloon valvotomy
Many centers use balloon dilatation in order to treat
critical aortic stenosis in infants. These centers display
good results with low mortality and low rate of severe
aortic regurgitation [5–7]. In the study of Mc Elhinney
and al. about 113 infants under 2 months of age, freedom
from surgical reintervention and aortic valve replacement
was respectively 64 and 76 % at 10 years and early mortal-
ity was 4 % between 1994 and 2002 [7].
Ross Procedure in Neonates and Infants
Ross procedure is an attractive surgical choice because
of the advantages of optimal size match between the
pulmonary autograft and the smaller aortic annulus;
these patients’ pulmonary valves may be better suited
to systemic pressures than the valves of older patients.
However, the disadvantages include placing two valves
at risk for a single valve disease and the risk of late dila-
tation of the autograft, which may result in aortic insuf-
ficiency [27–29].
Fig. 5 ROC curve of z-score of aortic annulus as risk factor
of mortality
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Aortic valve replacement in neonates and young infants
is associated with substantial mortality, ranking among
the highest risk of all cardiac procedures in these age
groups [30].
However, in the study of Shinkawa and al. concern-
ing Ross procedure in 31 neonates and infants, the
intermediate-term results are acceptable with actuarial
survival rate at 10 years of 76.7 % and freedom from
reoperation of 50.6 % at 10 years [31].
Two-stage biventricular rehabilitation for severe left
ventricular dysfunction
Ventricular dysfunction is common in critical aortic
stenosis and is associated with higher mortality re-
gardless of the type of management (surgical or balloon
valvotomy). Some centers have reported a two-stage
biventricular rehabilitation (surgical or hybrid approaches)
in order to improve recovery of left ventricular dimensions
and contractility, and also improve right ventricular
hemodynamics during the temporary right ventricular-
dependent systemic circulation. However, these are still
experimental studies with low numbers of patients [32–34].
Study limitations
This is a retrospective single-center study with loss of
data in the medical records.
Conclusion
The experience, in our center, on the management of
critical aortic stenosis, shows a low early and late mor-
tality (actuarial survival rate at 15 years: 85 %), but the
aortic valvotomy is a palliative procedure and we see un-
fortunately a high rate of reintervention among which
the aortic valve replacement. These results suggest to re-
consider the use of aortic balloon valvotomy, and par-
ticularly for the neonates with a low cardiac output in
order to avoid the myocardial stress and the neurological
injury due to the cardiopulmonary bypass.
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